FATE Historical PE Ratio image   This FATE PE ratio history page last updated 5/6/2022
FATE Historical PE Ratio Chart
Data adjusted for FATE split history

PeriodPriceGAAPAnnualizedPE
Q1 2022
5/4/2022
30.69-0.68-2.72NA
Q4 2021
2/28/2022
34.55-0.72-2.88NA
Q3 2021
11/4/2021
59.65-0.45-1.80NA
Q2 2021
8/4/2021
85.73-0.58-2.32NA
Q1 2021
5/5/2021
77.73-0.48-1.92NA
Q4 2020
2/24/2021
95.27-0.61-2.44NA
Q3 2020
11/5/2020
49.92-0.68-2.72NA
Q2 2020
8/5/2020
32.84-0.35-1.40NA
Q1 2020
5/11/2020
30.22-0.44-1.76NA
Q4 2019
3/2/2020
31.01-0.37-1.48NA
Q3 2019
11/5/2019
15.71-0.40-1.60NA
Q2 2019
8/6/2019
19.82-0.36-1.44NA
Q1 2019
5/7/2019
16.98-0.30-1.20NA
Q4 2018
3/5/2019
16.03-0.25-1.00NA
Q3 2018
11/1/2018
13.61-0.31-1.24NA
Q2 2018
8/6/2018
10.17-0.37-1.48NA
Q1 2018
5/10/2018
10.96-0.27-1.08NA
Q4 2017
3/5/2018
13.77-0.29-1.16NA
Q3 2017
11/1/2017
4.69-0.26-1.04NA
Q2 2017
8/14/2017
3.09-0.23-0.92NA
Q1 2017
5/15/2017
4.11-0.24-0.96NA
Q4 2016
3/16/2017
4.64-0.21-0.84NA
Q3 2016
11/7/2016
1.97-0.27-1.08NA
Q2 2016
8/8/2016
2.59-0.29-1.16NA
Q1 2016
5/9/2016
1.73-0.29-1.16NA
Q4 2015
3/3/2016
1.83-0.26-1.04NA
Q3 2015
11/3/2015
4.52-0.24-0.96NA
Q2 2015
8/5/2015
6.87-0.33-1.32NA
Q1 2015
5/7/2015
7.19-0.38-1.52NA
Q4 2014
3/12/2015
5.08-0.30-1.20NA
Q3 2014
11/11/2014
3.95-0.32-1.28NA
Q2 2014
8/12/2014
6.00-0.30-1.20NA
Q1 2014
5/13/2014
6.56-0.34-1.36NA
Q4 2013
3/17/2014
10.43-0.29-1.16NA
Q3 2013
11/13/2013
5.16-4.81-19.24NA
FATE PE History Chart
PeriodPriceGAAPTTMPE
Q1 2022
5/4/2022
30.69-0.68-2.43NA
Q4 2021
2/28/2022
34.55-0.72-2.23NA
Q3 2021
11/4/2021
59.65-0.45-2.12NA
Q2 2021
8/4/2021
85.73-0.58-2.35NA
Q1 2021
5/5/2021
77.73-0.48-2.12NA
Q4 2020
2/24/2021
95.27-0.61-2.08NA
Q3 2020
11/5/2020
49.92-0.68-1.84NA
Q2 2020
8/5/2020
32.84-0.35-1.56NA
Q1 2020
5/11/2020
30.22-0.44-1.57NA
Q4 2019
3/2/2020
31.01-0.37-1.43NA
Q3 2019
11/5/2019
15.71-0.40-1.31NA
Q2 2019
8/6/2019
19.82-0.36-1.22NA
Q1 2019
5/7/2019
16.98-0.30-1.23NA
Q4 2018
3/5/2019
16.03-0.25-1.20NA
Q3 2018
11/1/2018
13.61-0.31-1.24NA
Q2 2018
8/6/2018
10.17-0.37-1.19NA
Q1 2018
5/10/2018
10.96-0.27-1.05NA
Q4 2017
3/5/2018
13.77-0.29-1.02NA
Q3 2017
11/1/2017
4.69-0.26-0.94NA
Q2 2017
8/14/2017
3.09-0.23-0.95NA
Q1 2017
5/15/2017
4.11-0.24-1.01NA
Q4 2016
3/16/2017
4.64-0.21-1.06NA
Q3 2016
11/7/2016
1.97-0.27-1.11NA
Q2 2016
8/8/2016
2.59-0.29-1.08NA
Q1 2016
5/9/2016
1.73-0.29-1.12NA
Q4 2015
3/3/2016
1.83-0.26-1.21NA
Q3 2015
11/3/2015
4.52-0.24-1.25NA
Q2 2015
8/5/2015
6.87-0.33-1.33NA
Q1 2015
5/7/2015
7.19-0.38-1.30NA
Q4 2014
3/12/2015
5.08-0.30-1.26NA
Q3 2014
11/11/2014
3.95-0.32-1.25NA
Q2 2014
8/12/2014
6.00-0.30-5.74NA
Q1 2014
5/13/2014
6.56-0.34NANA
Q4 2013
3/17/2014
10.43-0.29NANA
Q3 2013
11/13/2013
5.16-4.81NANA
Quotes delayed 20 minutes

Email EnvelopeFree FATE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Fate Therapeutics (FATE) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

FBIO PE Ratio History
FBRX PE Ratio History
FDMT PE Ratio History
FEMY PE Ratio History
FGEN PE Ratio History
FHTX PE Ratio History
FIGS PE Ratio History
FIXX PE Ratio History
FLDM PE Ratio History
FLGT PE Ratio History
How should the FATE historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Fate Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this FATE Historical PE Ratio page.

What is the average historical PE for FATE based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The FATE historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for FATE based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The FATE historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the FATE Historical PE Ratio information for Fate Therapeutics' stock. The average FATE historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average FATE historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this FATE historical PE result, against the recent PE: when this page was posted on 5/5/2022, the most recent closing price for FATE had been 27.19, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on FATE or any other given stock, valuation analysis for FATE can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Fate Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for FATE. Thanks for visiting, and the next time you need to research FATE Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: AB Average Annual Return, Institutional Holders of SMCI, ATTO Videos.

 

FATE Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.